SUMMARY The assessment of granulocyte chemotaxis is complicated by the difficulty of precisely reproducing results in serial estimations and deciding on the best end point which would reflect most accurately the degree of travel taken by the cells under observation. The methods in use are generally based on the Boyden chamber;' following this, we have further developed the principle of the "raft" technique of chamber based migration.2 In order to overcome the problems associated with reproducibility of results when performing multiple assays of chemotaxis, especially when sera of widely differing activity are encountered in the screening procedure, we have used a "batching" system and a simple method of presenting the results so that they are comparable.
The means of quantifying the degree of granulocyte migration most commonly employed is the "leading front" method;3 we have found this unsatisfactory even at 90 min for faster-moving granulocytes or stronger chemoattractants, as some of the cells move beyond the membrane and may be lost to assay.34 In these circumstances, three possible solutions exist:
(i) the micropore membrane could be thickermany authors5 6 say they have been unable to find membranes of standardised thickness and quality and until manufacturers can correct this and provide thicker membranes this solution remains theoretical.
(ii) use a weaker chemotaxin; sometimes assays are done for the express purpose of looking for decreased migration-for example, when an inhibitor is present; in such cases designated chemotaxins need to be used against the special nature of the inhibitor-for example, C5a for C5a specific inhibitor.7 8 Thus the second solution has limited application.
(iii) a shortening of incubation time from 3 h to around 60 to 90 min has already been employed by all the investigators using the "leading front" estimation.
However, if one is looking for inhibitors, then the chemotaxin should give relatively long leading fronts so that shortening can be more clearly observed. In our work we regularly use an attractant which produced a leading front of at least 100,um in 90 min.
Some of the difficulties were overcome by Reservoirs for the stimulant consist of blank, clean antibiotic assay pads (Whatman, England) of 13 mm diameter capable of holding 200 ul of fluid at least.
The tests require a little dexterity to set up as the discs are placed on the islands in replicates touching each other, then the membranes are placed over the discs, and the whole saturated from below with obtained. In Fig. 4 Fig. 4 that there is a correlation between LI and m value, albeit a biphasic one where there is a steep deviation from the initial incline when LI > 60. This is to be expected as there is undervaluation of the LI when the speed of the fastest-moving cells are all approximated to 120 ,urm. We find pooled AB serum a potent chemotaxin but can only compare the attractant activity of these sera and also normal sera of various blood groups using their migration gradients; neither the leading front nor the LI could be accurately calculated from the figures obtained after the 90 min incubation. For known slow-moving cells or weak attractants the LI or even the leading front estimation can be of course used as the simple method of reporting chemotaxis, and we continue to use the latter for convenience when comparing such materials.
The data suggest that our method is more useful than the LI and more easily standardised and it is *The migrated cells were counted at 10 ,um intervals from the original monolayer on the cell surface. The number of cells per high power field at each level was multiplied by the distance of that level from the starting surface. The products were added and the sum was then divided by the total number of cells at all layers counted per high power field. The results mnake up the LI for that incubation time.
eminently suitable for looking at the pattern of migration as opposed to the average speed of a cell whatever the speed of migration. We confirm that the raft technique is well suited for routine multiple screening, especially if performed as described here.
